PFS and OS after CAR-T cell or alloHCT according to the CIBMTR prognostic score
| . | Low risk (score 0) . | Intermediate risk (score 2,4,5) . | High/very high risk (score 6,7,9,11) . | Overall P . | |
|---|---|---|---|---|---|
| CAR-T cohort | 1-y OS (95% CI) | 88.4 (78.4-95.6) | 76.4 (65.4-85.8) | 52.8 (38.5-66.9) | <.001 |
| 1-y PFS (95% CI) | 75.8 (62.9-86.6) | 54.3 (42.3-66.1) | 34.9 (21.9-49.1) | <.001 | |
| alloHCT cohort | 1-y OS (95% CI) | 73.3 (67.1-79.1) | 59.9 (51.9-67.7) | 46.3 (31.5-61.5) | .002 |
| 1-y PFS (95% CI) | 62.6 (55.9-69.1) | 46.6 (38.4-54.9) | 34.1 (20.6-49.2) | <.001 | |
| . | Low risk (score 0) . | Intermediate risk (score 2,4,5) . | High/very high risk (score 6,7,9,11) . | Overall P . | |
|---|---|---|---|---|---|
| CAR-T cohort | 1-y OS (95% CI) | 88.4 (78.4-95.6) | 76.4 (65.4-85.8) | 52.8 (38.5-66.9) | <.001 |
| 1-y PFS (95% CI) | 75.8 (62.9-86.6) | 54.3 (42.3-66.1) | 34.9 (21.9-49.1) | <.001 | |
| alloHCT cohort | 1-y OS (95% CI) | 73.3 (67.1-79.1) | 59.9 (51.9-67.7) | 46.3 (31.5-61.5) | .002 |
| 1-y PFS (95% CI) | 62.6 (55.9-69.1) | 46.6 (38.4-54.9) | 34.1 (20.6-49.2) | <.001 | |